This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
October 19, 2020
Updated CERAMENT BONE VOID FILLER (BVF) instructions for use for the US market
October 19, 2020
Oncopeptides has submitted an Investigational New Drug application to FDA for the second drug candidate from the PDC platform
October 15, 2020
GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update
October 15, 2020
Orexo and Lyfebulb Announce the Winner of the 2020 Innovation Challenge in Substance Use Disorders
October 14, 2020
Aprea Therapeutics Launches Disease Awareness Website for Healthcare Professionals, p53reactivation.com
October 14, 2020
GenSight Biologics Appoints Elsy Boglioli to its Board of Directors
October 14, 2020
Targovax ASA – successfully completed private placement
October 14, 2020
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 14, 2020
Oncopeptides signs € 40 million loan agreement with the EIB
October 13, 2020
Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer